Hepatology is a medical specialty focusing on the structure, function, pathology and disorders of the liver, gall bladder and bile ducts.
hepatitis B virus
hepatitis C virus
If the astounding progress in the discipline of hepatology over the past 35 years is any indication of the future, the next 35 years will advance in ways that may be unrecognizable by today’s standards. Moreover, we tend to underestimate the long-term impact of discovery in science. As the US Astronaut Neil Armstrong once remarked, “Science has not yet mastered prophecy. We predict too much for the next year and far too little for the next 10.”
Using the past as a guide, however, it is safe to predict that change will continue to accelerate in hepatology based on five major paradigm shifts that are already transforming medicine, from the cellular to the societal levels. The first of these shifts is driven by the genomic and epigenomic revolutions that can personalize medicine by identifying genetic risks that lead to disease prevention. This concept of “precision medicine” has been recently identified by President Obama as a high priority for funding by the US National Institutes of Health. We are now able to classify diseases in new ways that will enable treatments to be customized. These genetic and epigenetic classifications clarify how the environment, the microbiome, social interactions, and even parental behaviors influence gene expression in development, health and disease. The second sea change is based on the potential of advances in stem cell biology and cellular plasticity to reprogram adult cells, accelerate tissue repair, and design cell-based therapies. Third, remarkable developments in nanotechnology and imaging are yielding novel noninvasive diagnostics, cellular delivery systems, and scaffolds for tissue support and repair. Fourth, there is rising pressure for cost containment by preventing disease and reorganizing health care delivery systems. Finally, patient empowerment through the use of mobile technologies that relay medical information directly to patients and enhance their engagement in decision-making is dramatically affecting medical care, including gastroenterology and hepatology.
With the emergence of highly effective oral therapies to cure HCV and suppress hepatitis B virus (HBV), and the future prospect of curative HBV therapies, other diseases will comprise a growing fraction of the hepatologist’s practice. Prominent among these are both alcoholic and nonalcoholic liver diseases. Alcoholic liver disease remains a terribly neglected public health threat, as reflected in our inability to either curtail high-risk drinking or to prevent severe liver injury in those who drink to excess, with no imminent prospects for improvement.
Patients who have the following – Type 2 Diabetes, High Blood Pressure, are Overweight or suspected Metabolic syndrome
Our centers of excellence in Hepatology and Hepatobiliary surgery consists of teams of hepatologists and hepatobiliary surgeons addressing all medical and surgical diseases related to the hepatobiliary system. With the use of advanced technology and surgical methods, patients now have more options than ever for the treatment of Hepatobiliary disease.
For patients requiring hospitalization, we have a dedicated Hepatobiliary critical care unit, a Hepatobiliary physician on-call, anesthetists and a specialized O.R. nursing team. Our focus is on providing experienced, personalized care for all our patients. Our doctors are trained at the world’s most renowned centers in Hepatobiliary surgery and Liver Transplantation and are actively involved in clinical research.
Our team of surgeons, interventional endoscopists, radiologists and hepatologists work together to provide surgical treatments.